Literature DB >> 18337488

Ectopic notch activation in developing podocytes causes glomerulosclerosis.

Aoife M Waters1, Megan Y J Wu, Tuncer Onay, Jacob Scutaru, Ju Liu, Corrinne G Lobe, Susan E Quaggin, Tino D Piscione.   

Abstract

Genetic evidence supports an early role for Notch signaling in the fate of podocytes during glomerular development. Decreased expression of Notch transcriptional targets in developing podocytes after the determination of cell fate suggests that constitutive Notch signaling may oppose podocyte differentiation. This study determined the effects of constitutive Notch signaling on podocyte differentiation by ectopically expressing Notch's intracellular domain (NOTCH-IC), the biologically active, intracellular product of proteolytic cleavage of the Notch receptor, in developing podocytes of transgenic mice. Histologic and molecular analyses revealed normal glomerular morphology and expression of podocyte markers in newborn NOTCH-IC-expressing mice; however, mice developed severe proteinuria and showed evidence of progressive glomerulosclerosis at 2 wk after birth. Features of mature podocytes were lost: Foot processes were effaced; expression of Wt1, Nphs1, and Nphs2 was downregulated; cell-cycle re-entry was induced; and the expression of Pax2 was increased. In contrast, mice with podocyte-specific inactivation of Rbpsuh, which encodes a protein essential for canonical Notch signaling, seemed normal. In addition, the damaging effects of NOTCH-IC expression were prevented in transgenic mice after simultaneous conditional inactivation of Rbpsuh in murine podocytes. These results suggest that Notch signaling is dispensable during terminal differentiation of podocytes but that constitutive (or inappropriate) Notch signaling is deleterious, leading to glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337488      PMCID: PMC2396929          DOI: 10.1681/ASN.2007050596

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  49 in total

1.  Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.

Authors:  T Ohtsuka; M Ishibashi; G Gradwohl; S Nakanishi; F Guillemot; R Kageyama
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

2.  Segmental expression of Notch and Hairy genes in nephrogenesis.

Authors:  Linghong Chen; Qais Al-Awqati
Journal:  Am J Physiol Renal Physiol       Date:  2005-05

3.  Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron.

Authors:  Hui-Teng Cheng; Mijin Kim; M Todd Valerius; Kameswaran Surendran; Karin Schuster-Gossler; Achim Gossler; Andrew P McMahon; Raphael Kopan
Journal:  Development       Date:  2007-01-17       Impact factor: 6.868

4.  Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

Authors:  Vera Eremina; Shiying Cui; Hanspeter Gerber; Napoleone Ferrara; Jody Haigh; Andras Nagy; Masatsugu Ema; Janet Rossant; Serge Jothy; Jeffrey H Miner; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2006-01-25       Impact factor: 10.121

5.  Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability.

Authors:  Chin-Tong Ong; Hui-Teng Cheng; Li-Wei Chang; Toshiyuki Ohtsuka; Ryoichiro Kageyama; Gary D Stormo; Raphael Kopan
Journal:  J Biol Chem       Date:  2005-12-19       Impact factor: 5.157

6.  Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockout mice.

Authors:  Shiying Cui; Chengjin Li; Masatsugu Ema; Jordan Weinstein; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2005-10-05       Impact factor: 10.121

7.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

8.  A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.

Authors:  C E Patek; M H Little; S Fleming; C Miles; J P Charlieu; A R Clarke; K Miyagawa; S Christie; J Doig; D J Harrison; D J Porteous; A J Brookes; M L Hooper; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes.

Authors:  Nina Jones; Ivan M Blasutig; Vera Eremina; Julie M Ruston; Friedhelm Bladt; Hongping Li; Haiming Huang; Louise Larose; Shawn S-C Li; Tomoko Takano; Susan E Quaggin; Tony Pawson
Journal:  Nature       Date:  2006-03-08       Impact factor: 49.962

10.  WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.

Authors:  Y Yang; C Jeanpierre; G R Dressler; M Lacoste; P Niaudet; M C Gubler
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more
  63 in total

1.  Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.

Authors:  Mariana Murea; Jun-Ki Park; Shuchita Sharma; Hideki Kato; Antje Gruenwald; Thiruvur Niranjan; Han Si; David B Thomas; James M Pullman; Michal L Melamed; Katalin Susztak
Journal:  Kidney Int       Date:  2010-06-09       Impact factor: 10.612

2.  The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development.

Authors:  Ramon G B Bonegio; Laurence H Beck; Roopkiranjot K Kahlon; Weining Lu; David J Salant
Journal:  Kidney Int       Date:  2011-01-26       Impact factor: 10.612

3.  Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.

Authors:  Junnan Wu; Chunxia Zheng; Yun Fan; Caihong Zeng; Zhaohong Chen; Weisong Qin; Changming Zhang; Wanfen Zhang; Xiao Wang; Xiaodong Zhu; Mingchao Zhang; Ke Zen; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

4.  Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.

Authors:  Bernhard Bielesz; Yasemin Sirin; Han Si; Thiruvur Niranjan; Antje Gruenwald; Seonho Ahn; Hideki Kato; James Pullman; Manfred Gessler; Volker H Haase; Katalin Susztak
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

5.  Notch2 activation in the embryonic kidney depletes nephron progenitors.

Authors:  Sayoko Fujimura; Qing Jiang; Chiyoko Kobayashi; Ryuichi Nishinakamura
Journal:  J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 10.121

6.  Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy.

Authors:  Madhulika Sharma; Lynn K Magenheimer; Trisha Home; Karen N Tamano; Pravin C Singhal; Deborah P Hyink; Paul E Klotman; Gregory B Vanden Heuvel; Timothy A Fields
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

Review 7.  The pathogenic role of Notch activation in podocytes.

Authors:  Thiruvur Niranjan; Mariana Murea; Katalin Susztak
Journal:  Nephron Exp Nephrol       Date:  2009-03-17

Review 8.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

Review 9.  Notch: A multi-functional integrating system of microenvironmental signals.

Authors:  Bryce LaFoya; Jordan A Munroe; Masum M Mia; Michael A Detweiler; Jacob J Crow; Travis Wood; Steven Roth; Bikram Sharma; Allan R Albig
Journal:  Dev Biol       Date:  2016-08-24       Impact factor: 3.582

10.  ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases.

Authors:  Paul Gutwein; Anja Schramme; Mohamed Sadek Abdel-Bakky; Kai Doberstein; Ingeborg A Hauser; Andreas Ludwig; Peter Altevogt; Stefan Gauer; Anja Hillmann; Thomas Weide; Christine Jespersen; Wolfgang Eberhardt; Josef Pfeilschifter
Journal:  J Biomed Sci       Date:  2010-01-13       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.